Related Experiment Video
Updated: Jun 25, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Immunotherapy in Sarcoma: Current Data and Promising Strategies.
Georgina E Wood1, Christian Meyer2, Florent Petitprez3
1University College Hospital of London, London, United Kingdom.
Sarcomas, once thought immune-silent, show potential for immunotherapy. Some bone and soft tissue sarcomas are
Area of Science:
- Oncology and Immunology
Background:
- Sarcomas traditionally exhibit low tumor mutational burden (TMB) and an immunosuppressive tumor microenvironment (TME).
- However, a subset of sarcomas are immunologically 'hot,' with high TMB, PD-L1 expression, CD8+ T cells, or tertiary lymphoid structures (TLS).
- These 'hot' sarcomas demonstrate sensitivity to immunotherapy.
Purpose of the Study:
- To review current evidence on immunotherapy for bone sarcomas (BS) and soft tissue sarcomas (STS).
- To explore various immunotherapy modalities and biomarkers of response.
Main Methods:
- Review of existing research on immunotherapy in bone and soft tissue sarcomas.
- Analysis of immune checkpoint inhibitors (ICI) and adoptive cellular therapies.
- Examination of chimeric antigen receptor (CAR) T-cell therapies, tumor-infiltrating lymphocytes (TILs), and cancer vaccines.
Main Results:
- Evidence suggests certain sarcomas are responsive to immunotherapy.
- Immune checkpoint inhibitors (ICI) and adoptive cellular therapies show promise.
- Biomarkers are crucial for predicting response to these treatments.
Conclusions:
- Immunotherapy represents a growing area of treatment for specific sarcoma subtypes.
- Further research into biomarkers and novel therapeutic strategies is warranted.
- Targeting the immune microenvironment holds potential for improving sarcoma outcomes.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...